Clare specialises in corporate and securities law, with a particular focus on equity capital markets, venture capital and M&A.
She has experience in cross-border and domestic corporate transactions including advising on equity fundraisings, private financing and investment transactions, regulated and private M&A, joint ventures, and securities regulatory and ASX compliance issues. Clare also advises on corporate governance matters and employee equity schemes.
She regularly acts for companies and investors in the healthcare, medical device and biotechnology sector, as well as the technology industry more broadly. Clare also regularly represents early and growth stage companies and the venture capital firms that invest in them.
Clare has significant experience advising US clients doing business in Australia and Australian clients doing business in the US, including having acted for a number of US companies listed on ASX.
Work highlights
CurveBeam AI Limited
Several transactions, including its merger with Curvebeam LLC, its initial public offering and listing on the ASX, and its ANREO and institutional placement.
EBR Systems Inc
A$110 million IPO and ASX listing, its institutional placement and SPP and its fully underwritten ANREO and institutional placement.
Imricor Medical Systems Inc.
Several transactions, including its pre-IPO financing, IPO and ASX listing and follow-on capital raisings (including its ANREO and two-tranche placement).
OneVentures Healthcare Fund
Various investments, including ImmVirX and BiVACOR.
Seven West Media Investments
Various investments, including Mad Paws.
Simplify Medical Pty Ltd
Acquisition by NuVasive, Inc. for US$150 million plus additional milestone payments.